Safety and durable immunogenicity of the TV005 tetravalent dengue vaccine, across serotypes and age groups, in dengue-endemic Bangladesh: a randomised, controlled trial

https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00520-0/fulltext?dgcid=hubspot_update_feature_updatealerts_laninf&utm_campaign=update-laninf&utm_medium=email&_hsmi=292975442&_hsenc=p2ANqtz-9_diYKa-N1dddw_32mOiGqFR49qqYpOusGHKR-kmGKJxn0iZzht0vzCDRbiatI0ruwKcjdbWSy-sIP5rbGewNFB6EwMw&utm_content=292924437&utm_source=hs_email